biotech · Hypertension · Essential Hypertension · QNTM
Quantum Pharmaceuticals
Quantum Biopharma
Quantum Pharmaceuticals is a biotech organization headquartered in Moscow, CA. It trades on NYSE under ticker QNTM. Primary therapeutic focus areas include Hypertension, Essential Hypertension, Breast Cancer, Metastatic
volkova 6A-1206, Moscow, 141700, RU, CA HQ
2004 Founded
29 Employees
Public company Type
QNTM · NYSE Ticker
Company details
- Status
- Public
- HQ
- volkova 6A-1206, Moscow, 141700, RU, CA
- Founded
- 2004
- Employees
- 29
- Programs
- 18
- Drugs
- 17
- Patents
- 36
Firibastat (QGC001) Period 1
Phase 3 · small molecule · Hypertension (HTN)
Firibastat (QGC001) Period 1 for Hypertension (HTN) is a Phase 3 program (small_molecule) at Quantum Biopharma with 1 ClinicalTrials.gov record(s).
Internal code QGC001-3QG2
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Quantum Biopharma
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Hypertension (HTN)
- Status
- terminated
- Trials
- 1